Cargando…
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
Background: Poor pharmacokinetic profiles and resistance are the main two drawbacks from which currently used antiviral agents suffer, thus make them excellent targets for research, especially in the presence of viral pandemics such as HIV and hepatitis C. Methods: The strategies employed in the stu...
Autores principales: | Sinokrot, Hanadi, Smerat, Tasneem, Najjar, Anas, Karaman, Rafik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151663/ https://www.ncbi.nlm.nih.gov/pubmed/29035325 http://dx.doi.org/10.3390/molecules22101736 |
Ejemplares similares
-
Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018) -
Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
por: Najjar, Anas, et al.
Publicado: (2020) -
Recent Advances in Molecular Mechanisms of Nucleoside Antivirals
por: Kamzeeva, Polina N., et al.
Publicado: (2023) -
Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals
por: Gollnest, Tristan, et al.
Publicado: (2015) -
Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies
por: Xu, Xingxing, et al.
Publicado: (2023)